*Significant difference (p < 0 05) as compared with the controls

*Significant difference (p < 0.05) as compared with the controls without

LPS treatment. Notably, MMP-3 transcript was differentially expressed in the cells treated by the two isoforms of P. gingivalis LPS. P. gingivalis LPS1690 significantly upregulated MMP-3 mRNA CB-5083 chemical structure expression at 24 and 48 h, while E. coli LPS showed prompt expression at 12 h (Figure 2c). MMP-2 mRNA was significantly upregulated by both P. gingivalis LPS1435/1449 and LPS1690 at 48 h (Figure 2b), and MMP-1 transcript was significantly upregulated by P. gingivalis LPS1690 (Figure 2a). E. coli LPS significantly upregulated both MMP-1 and MMP-2 mRNA expression. TIMP-1 transcript was differently modulated by P. gingivalis LPS1435/1449 and LPS1690. The former significantly upregulated its expression at 24 and 48 h, so did E. coli LPS at 48 h. Figure 2 Time-dependent expression of

MMPs 1−3 and TIMP-1 mRNAs in P. gingivalis LPS-treated HGFs. Expression of MMP-1 (a), MMP-2 (b) MMP-3 (c) and GW 572016 TIMP-1(d) mRNAs after the stimulation of P. gingivalis (Pg) LPS 1435/1449 (1 μg/ml), LPS1690 (1 μg/ml) and E. coli LPS (1 μg/ml) in a time-dependent assay (2–48 h). The expression of mRNAs was measured by real-time qPCR. Each bar represents the mean ± SD of three independent experiments with three replicates. *Significant difference (p < 0.05) HER2 inhibitor as compared with the controls without LPS treatment. P. gingivalis LPS1690 significantly upregulates MMP-3 protein expression Both dose- and time-dependent experiments showed that MMP-3 protein was differentially modulated by P. gingivalis LPS1435/1449 and LPS1690 in consistent with its transcript expression profile (Figure 3). P. gingivalis LPS1690 at 1 μg/ml and 10 μg/ml significantly upregulated MMP-3 protein expression in a time-dependent manner (12–48 h) (Figure 3c). The MMP-3 level detected in the culture supernatant was greatly higher than that in the cellular fraction (Figures 3a and b). Similar observations occurred in E. coli LPS-treated cells. Moreover, the MMP-3 Meloxicam level induced by P. gingivalis LPS1690

was significantly greater than that stimulated by P. gingivalis LPS1435/1449 (Figures 3a-c). Figure 3 P. gingivalis LPS 1690 significantly upregulates the expression of MMP-3 proteins. Expression of MMP-3 proteins in the culture supernatants (a) and cellular fractions (b) of HGFs after the stimulation of P. gingivalis (Pg) LPS1435/1449, LPS1690 and E. coli LPS in a dose-dependent assay (1 ng/ml, 10 ng/ml, 100 ng/ml, 1 μg/ml and 10 μg/ml) for 24 h. Time-dependent expression of MMP-3 proteins in the culture supernatants (c) of HGFs after the stimulation of P. gingivalis LPS 1435/1449 (1 μg/ml), LPS1690 (1 μg/ml) and E. coli LPS (1 μg/ml) for 2–48 h. The protein expression levels were measured by ELISA. Each bar represents the mean ± SD of two independent experiments with three replicates. Significant difference as compared with the controls without LPS treatment, *p < 0.05.

Comments are closed.